Evidence map›Paper›PMID 33156838›Full record

ArticlePloS one2020

RETRACTED: Potential synergistic activity of quercetin with antibiotics against multidrug-resistant clinical strains of Pseudomonas aeruginosa.

Chembili Vipin, Kanekar Saptami, Fathima Fida, Musliyarakath Mujeeburahiman, Sneha S Rao, Athmika, Ananthapadmanabha Bhagwath Arun, Punchappady Devasya Rekha

RetractedOpen access · goldAbstract readRetracted Publication
In one paragraph

Article in PloS one, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 64 papers.

0numbers the graph read from it
0cells of the map it votes in
64citing papers in PubMed
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

64 citing papers in PubMed, 109 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Current computer-aided drug design · 2025
    Article
  19. Article
  20. Review

4 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Chembili VipinYenepoya Research Centre, Yenepoya (Deemed to be University), Mangalore, Karnataka, India.
Kanekar SaptamiYenepoya Research Centre, Yenepoya (Deemed to be University), Mangalore, Karnataka, India.ORCID 0000-0002-1508-5305
Fathima FidaYenepoya Research Centre, Yenepoya (Deemed to be University), Mangalore, Karnataka, India.
Musliyarakath MujeeburahimanDepartment of Urology, Yenepoya (Deemed to be University), Mangalore, Karnataka, India.
Sneha S RaoYenepoya Research Centre, Yenepoya (Deemed to be University), Mangalore, Karnataka, India.
AthmikaYenepoya Research Centre, Yenepoya (Deemed to be University), Mangalore, Karnataka, India.
Ananthapadmanabha Bhagwath ArunYenepoya Research Centre, Yenepoya (Deemed to be University), Mangalore, Karnataka, India.ORCID 0000-0003-3140-9266
Punchappady Devasya RekhaYenepoya Research Centre, Yenepoya (Deemed to be University), Mangalore, Karnataka, India.ORCID 0000-0002-9187-6395
Yenepoya University · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Development of drug resistance in opportunistic pathogens is one of the major healthcare challenges associated with infection management. Combination therapy has many advantages due to the simultaneous action of two drugs on two separate cellular targets. However, selection of the drugs should offer safety and synergistic interaction against most of the strains. Here, the efficacy of antibiotics in combination with quercetin, a natural flavonoid capable of targeting quorum sensing was tested against biofilm-forming Pseudomonas aeruginosa strains previously isolated from catheter associated urinary tract infection. Based on the antibiotic susceptibility pattern, synergistic effect of quercetin with selected antibiotics (levofloxacin, ceftriaxone, gentamycin, tobramycin and amikacin) was tested at the fractional concentrations of MIC by the checkerboard method and the fractional inhibitory concentration index (FICi) was calculated to estimate the synergistic effect. Effect of the synergistic combinations were further tested using time-kill assay, and against biofilm formation and biofilm cell viability. Cytotoxicity assays were performed using Human Embryonic Kidney 293T cells (HEK-293T) using the effective drug combinations with respective controls. The biofilm formation and biofilm cell viability were drastically affected with quercetin and selected antibiotics combinations with ≥80% inhibition. In vitro infection studies showed that all the strains could exert significant cell killing (68 to 85%) and the drug combinations decreased the infection rate significantly by reducing the cell killing effect of P. aeruginosa (p<0.05). The synergistic effect of quercetin is attributed to its quorum sensing inhibitory properties. These findings indicate that quercetin along with existing antibiotics can potentiate the treatment against P. aeruginosa infection and may reduce the selection pressure due to antibiotic overuse.

Indexed as

Anti-Bacterial AgentsBiofilmsDrug Resistance, Multiple, BacterialDrug SynergismHEK293 CellsHumansMicrobial Sensitivity TestsMicrobial ViabilityPseudomonas aeruginosaQuercetinAnti-Bacterial AgentsQuercetin

Identifiers

PMID33156838
PMCPMC7647105
OpenAlexW3096978385

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.